Stock market today: Stocks fall as investors rotate out of tech into Jackson Hole
Investing.com -- Zoetis (NYSE:ZTS) shares climbed more than 2% in premarket trading Tuesday after the pets and livestock drugmaker offered full-year guidance and reported first-quarter results that beat average analyst expectations.
The company reported Q1 earnings per share (EPS) of $1.48, ahead of the consensus estimate of $1.41. Revenue rose 1.4% year-over-year to $2.22 billion, just above the consensus projection of $2.20 billion.
“Zoetis achieved strong results for the first quarter of 2025, driven by demand for our innovative products and our focus on delivering for our customers. It is a testament to our colleagues’ unwavering dedication and excellence in agility that we reported organic operational revenue growth of 9%," said Kristin Peck, CEO of Zoetis.
"While the external environment continues to evolve, we remain agile, disciplined and focused on supporting our customers and the animals in their care while continuing our commitment to deliver value to shareholders.”
For full-year 2025, the company now expects earnings per share between $6.20 and $6.30, ahead of the $6.06 consensus. Revenue is projected to range from $9.425 billion to $9.575 billion, also better than the $9.329 billion forecasted by analysts.
Zoetis updated its full-year revenue outlook to reflect foreign exchange impacts but maintained its guidance for 6% to 8% organic operational growth. The company also revised its forecast for adjusted net income growth to 5% to 7%, citing the effect of enacted tariffs.